Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RVNC | Revance Therapeutics, Inc. | Director | $222 K | May 4, 2022 | ||
AVRO | Tectonic Therapeutic, Inc. | Director | Jun 6, 2023 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|